Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions. Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II clinical trials for isolated osteocartilaginous lesions in the knee by mid 2024." title="" class="btn" data-container="body" data-html="true" data-id="91146" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Lamina Therapeutics"> 453
Activities
Technologies
Entity types
Location
1 Rue Eugène Boeckel, 67000 Strasbourg, France
Strasbourg
France
Employees
Scale: 2-10
Estimated: 4
Engaged corporates
15Added in Motherbase
4 years, 2 months agoDeveloping innovative implantable medical devices for orthopaedic applications
Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions.
Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II clinical trials for isolated osteocartilaginous lesions in the knee by mid 2024.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | LUTECH | Other 27 Nov 2024 | | |
![]() | SATT Nord | Other 27 Nov 2024 | | |
![]() | SATT Aquitaine Science Transfert | Other 27 Nov 2024 | | |
![]() | SATT AxLR | Other 27 Nov 2024 | | |
![]() PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 27 Nov 2024 | | |
![]() SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | Other 27 Nov 2024 | | |
![]() Erganeo Research, National and local authorities, Research Services | Erganeo Research, National and local authorities, Research Services | Other 27 Nov 2024 | | |
![]() SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Other 27 Nov 2024 | | |
![]() SAYENS Research, Startup accelerator & VC, Research Services | SAYENS Research, Startup accelerator & VC, Research Services | Other 27 Nov 2024 | | |
![]() SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | Other 27 Nov 2024 | |